PremiumCompany AnnouncementsShell Continues Capital Return With Latest £ and € Share Buy-Back Tranche1d ago
PremiumCompany AnnouncementsAstraZeneca’s EMBOLD-Asia Trial Signals Fresh Push Into Obesity Market2d agoAZN
PremiumCompany AnnouncementsAstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors2d agoAZN
PremiumCompany AnnouncementsBAT CEO Marroco Transfers Shares to Joint Account With Closely Associated Party2d ago